UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 175 filers reported holding UNIQURE NV in Q1 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $17,535,109 | +51.3% | 773,494 | +25.2% | 0.00% | +33.3% |
Q3 2022 | $11,585,932 | +73.3% | 617,587 | +72.2% | 0.00% | +50.0% |
Q2 2022 | $6,684,062 | +3.2% | 358,587 | 0.0% | 0.00% | +100.0% |
Q1 2022 | $6,479,667 | -24.0% | 358,587 | -12.7% | 0.00% | -50.0% |
Q4 2021 | $8,524,000 | -32.9% | 410,983 | +3.5% | 0.00% | -33.3% |
Q3 2021 | $12,706,000 | +33.6% | 396,947 | +28.6% | 0.00% | +50.0% |
Q2 2021 | $9,510,000 | -11.6% | 308,750 | -3.3% | 0.00% | 0.0% |
Q1 2021 | $10,752,000 | -23.0% | 319,131 | -17.4% | 0.00% | -33.3% |
Q4 2020 | $13,961,000 | -1.9% | 386,403 | 0.0% | 0.00% | -25.0% |
Q3 2020 | $14,231,000 | -12.4% | 386,403 | +7.2% | 0.00% | -20.0% |
Q2 2020 | $16,238,000 | -9.5% | 360,371 | -4.7% | 0.01% | -16.7% |
Q1 2020 | $17,940,000 | -33.8% | 378,092 | 0.0% | 0.01% | -25.0% |
Q4 2019 | $27,094,000 | +248.7% | 378,092 | +91.5% | 0.01% | +300.0% |
Q3 2019 | $7,769,000 | – | 197,395 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |